FilingReader Intelligence
Livzon appoints new vice president amid executive shift
April 23, 2025 at 05:54 PM UTC•By FilingReader AI
Livzon Pharmaceutical Group [SZSE: 000513] announced a shift in executive leadership, effective April 23, 2025. The company's board of directors approved the appointment of Xu Xiao as Vice President at the company’s latest board meeting. Xu will be responsible for production operations.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
Announcement on the Appointment of Senior Management PersonnelApril 23, 2025 at 09:00 AM UTC
2025 First Quarter ReportApril 23, 2025 at 09:00 AM UTC
Announcement on Cancellation of Part of the Stock Options under the 2022 Stock Option Incentive PlanApril 23, 2025 at 09:00 AM UTC
2024 Environmental, Social and Governance ReportApril 23, 2025 at 09:41 AM UTC
SZSE:000513•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when Livzon Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime